---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-003926"
form_type: "8-K"
ticker: "VRCA"
cik: "0001660334"
company_name: "Verrica Pharmaceuticals Inc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:22:18.530451+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Verrica updates company overview presentation; no material new data disclosed

## Summary
- Filing notes company presentation updated on website as of January 8, 2024.
- No specific financial, clinical, or operational metrics are provided in the exhibit.
- Presentation title slide only; substantive content not included in this filing.
- Furnished under Regulation FD, not incorporated by reference.

## SEC filing metadata
- accession: 0001193125-24-003926
- form_type: 8-K
- ticker: VRCA
- cik: 0001660334
- company_name: Verrica Pharmaceuticals Inc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1660334/000119312524003926/0001193125-24-003926-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1660334/000119312524003926/d109895d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-003926
- JSON: https://secwatch.observer/filing/0001193125-24-003926.json
- Plain text: https://secwatch.observer/filing/0001193125-24-003926.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.